Lymph Node Count Crucial for Pancreatic Cancer Survival
Early-stage pancreatic cancer outcomes hinge on lymph node counts, affecting surgical decisions.
Newsletter
HPB & Spleen
Every new paper in this field, in your inbox.
New Imaging Tech Outperforms CT for Pancreatic Cancer Surgery
Three-dimensional imaging technology may enhance surgical selection for neoadjuvant-treated pancreatic cancer patients.
Effective conversion strategies for unresectable liver cancer
Triple therapy regimens significantly improve surgical candidacy for patients with unresectable hepatocellular carcinoma.
Monitoring MPD Growth Crucial in IPMN Management
Dynamic changes in main pancreatic duct (MPD) diameter are key in predicting malignancy risk for patients with MPD-involved IPMN.
New diabetes risk model improves post-pancreatectomy care
Surgeons can leverage a simple scoring system to predict new-onset diabetes after distal pancreatectomy, enhancing patient management.
Piperacillin-tazobactam outperforms cefoxitin for pancreatoduodenectomy
Switching to piperacillin-tazobactam for prophylaxis significantly lowers surgical site infections and pancreatic fistula rates in open pancreatoduodenectomy.
Reassessing Surgery for Mucinous Cystic Neoplasms
Surgical interventions for mucinous cystic neoplasms (MCN) should be more selective based on updated risk factors.
Rising Early-Onset Pancreatic Cancer Burden in Asia
Early-onset pancreatic cancer is surging, demanding attention from surgeons.
Transforming HCC Surgery with Biology-Driven Approaches
Surgeons need to adapt to evolving strategies for hepatocellular carcinoma (HCC) that prioritize biological insights and dynamic eligibility criteria.
Guided Classification Improves Outcomes in Pancreatic Surgery
A new intraoperative classification system enhances pancreatic surgery for benign and low-grade tumors.